The body as a manufacturer of endostatin

被引：21

作者：

Crystal, RG ^{[1
]}

机构：

[1] Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA

来源：

NATURE BIOTECHNOLOGY | 1999年 / 17卷 / 04期

关键词：

D O I：

10.1038/7890

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

页码：336 / 337

页数：2

共 14 条

[1]

Anderson WF, 1998, NATURE, V392, P25

[2] Antiangiogenic tumour therapy: will it work? [J].

Augustin, HG .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (06) :216-222

[3] Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene [J].

Blezinger, P ;

Wang, JJ ;

Gondo, M ;

Quezada, A ;

Mehrens, D ;

French, M ;

Singhal, A ;

Sullivan, S ;

Rolland, A ;

Ralston, R ;

Min, W .

NATURE BIOTECHNOLOGY, 1999, 17 (04) :343-348

[4] Cancer therapy - Behind the headlines of endostatin's ups and downs [J].

Cohen, J .

SCIENCE, 1999, 283 (5406) :1250-1251

[5] TRANSFER OF GENES TO HUMANS - EARLY LESSONS AND OBSTACLES TO SUCCESS [J].

CRYSTAL, RG .

SCIENCE, 1995, 270 (5235) :404-410

[6] Antiangiogenic gene therapy [J].

Folkman, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) :9064-9066

[7]

King R, 1998, WALL STREET J 0520, VA1

[8]

Kolata G, 1998, NEW YORK TIMES NEW Y, P1

[9] Gene therapy strategies for tumor antiangiogenesis [J].

Kong, HL ;

Crystal, RG .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (04) :273-286

[10]

Narumi K, 1998, BLOOD, V92, P822

← 1 2 →